Design and synthesis of aryloxypropanolamine as β3-adrenergic receptor antagonist in cancer and lipolysis
作者:Jiyu Jin、Chunxiao Miao、Zhilong Wang、Wanli Zhang、Xiongwen Zhang、Xin Xie、Wei Lu
DOI:10.1016/j.ejmech.2018.03.032
日期:2018.4
β-adrenergic receptors (β-ARs) are broadly distributed in various tissues and regulate a panel of important physiological functions and disease states including cancer. Above all, β3-adrenergic receptor (β3-AR) plays a significant role in regulating lipolysis and thermogenesis in adipose tissue. In this study, we designed and synthesized a series of novel L-748,337 derivatives as selective human β3-AR
β-肾上腺素能受体(β-ARs)广泛分布在各种组织中,并调节一系列重要的生理功能和疾病状态,包括癌症。首先,β 3肾上腺素能受体(β 3 -AR)发挥了在脂肪组织中脂肪分解调节和产热一个显著的作用。在这项研究中,我们设计并合成了一系列新的L-748337衍生物作为选择性人β 3 -AR拮抗剂。在所有被测试的L-748337类似物,化合物23d中被发现显示23倍更有效的β 3 -AR拮抗剂活性(EC 50 = 0.5117 nM)的比L-748337(EC 50 = 11.91 nM)的。体内化合物23d 在C26肿瘤恶病质动物模型中可以减轻体重并抑制肿瘤生长。